103 related articles for article (PubMed ID: 902703)
1. Hydroxyurea (HU) in experimental hematology. I. Characterization of in vitro and in vivo effects on progenitor and transit cells.
Benestad HB; Warhuus K; Reikvam A
Exp Hematol; 1977 Sep; 5(5):408-14. PubMed ID: 902703
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea (HU) in experimental hematology. II. Similarities and dissimilarities between HU and 3H-thymidine killing.
Benestad HB
Exp Hematol; 1977 Sep; 5(5):415-22. PubMed ID: 902704
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-dependent heat sensitization of murine granulocyte-macrophage progenitor cells in regenerating marrow.
Kobayashi E; Yamagishi M; Kamamoto T; Yoshida Y; Uchino H
Cancer Res; 1985 Apr; 45(4):1459-63. PubMed ID: 3978612
[TBL] [Abstract][Full Text] [Related]
4. The suicide technique in vitro for granulocytic progenitor cells (CFC) by application of hydroxyurea (HU) to low concentrations of human bone marrow cells.
Morardet N; Charbord P; Parmentier C
Biomedicine; 1979 Feb; 31(1):4-5. PubMed ID: 476273
[TBL] [Abstract][Full Text] [Related]
5. Changes of bone marrow stromal cells (MSC) in mice after drug induced eradication of hematopoietic cells: in vitro effects on normal bone marrow.
Ben-Ishay Z; Prindull G; Sharon S
Biomed Pharmacother; 1982; 36(8-9):353-9. PubMed ID: 7182013
[TBL] [Abstract][Full Text] [Related]
6. Differential characterization of colony-forming units in diffusion chambers from pluripotent stem cells and progenitors of granulocytes/macrophages.
Ben-Ishay Z; Prindull G
Isr J Med Sci; 1982 Oct; 18(10):990-5. PubMed ID: 7174278
[TBL] [Abstract][Full Text] [Related]
7. The use of hydroxyurea to study the proliferative state of T-cell precursors (CFUT) in murine bone marrow.
Rusthoven JJ; Phillips RA
Exp Hematol; 1980 May; 8(5):578-83. PubMed ID: 6970140
[TBL] [Abstract][Full Text] [Related]
8. Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow.
Koller MR; Bender JG; Miller WM; Papoutsakis ET
Exp Hematol; 1992 Feb; 20(2):264-70. PubMed ID: 1544397
[TBL] [Abstract][Full Text] [Related]
9. Some methods of assaying inhibitors of cell proliferation.
Benestad HB; Rytömaa T; Svensson T
Exp Hematol; 1980 Sep; 8(8):961-70. PubMed ID: 6451445
[TBL] [Abstract][Full Text] [Related]
10. Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.
van 't Hull E; Schellekens H; Löwenberg B; de Vries MJ
Cancer Res; 1978 Apr; 38(4):911-4. PubMed ID: 639045
[TBL] [Abstract][Full Text] [Related]
11. [The precursor hematopoietic cell: its origin in ontogeny, proliferative activity and proliferative potential].
Deriugina EI; Drize NI; Olovnikova NI; Sadovnikova EIu; Chertkov IL
Ontogenez; 1991; 22(2):125-32. PubMed ID: 1857592
[TBL] [Abstract][Full Text] [Related]
12. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
Grant S; Pettit GR; McCrady C
Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
[TBL] [Abstract][Full Text] [Related]
13. Cell kinetics of erythroid colony-forming cells (CFU-E) studied by hydroxyurea injections and sedimentation velocity profile.
Udupa KB; Reissmann KR
Exp Hematol; 1978 Apr; 6(4):398-404. PubMed ID: 648597
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
15. Altered production and renewal of natural killer cells in B-lymphocyte-deficient CBA/N mice.
Miller SC; Christopher FL
Nat Immun Cell Growth Regul; 1989; 8(5):245-54. PubMed ID: 2594018
[TBL] [Abstract][Full Text] [Related]
16. Recovery of the proliferative and functional integrity of mouse bone marrow in long-term cultures established after whole-body irradiation at different doses and dose rates.
Bierkens JG; Hendry JH; Testa NG
Exp Hematol; 1991 Feb; 19(2):81-6. PubMed ID: 1991498
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the growth and cycling status of granulocyte-monocyte colony-forming units (CFU-GM) in rats injected single doses of aflatoxin B1.
Cukrová V; Kurita N; Akao M
Neoplasma; 1992; 39(2):93-6. PubMed ID: 1528314
[TBL] [Abstract][Full Text] [Related]
18. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.
Schaafsma MR; Falkenburg JH; Duinkerken N; Moreau JF; Soulillou JP; Willemze R; Fibbe WE
Exp Hematol; 1992 Jan; 20(1):6-10. PubMed ID: 1577095
[TBL] [Abstract][Full Text] [Related]
19. Biological time and the effects of hydroxyurea on DNA synthetic activity of bone marrow and tumor cells in mice bearing the Ehrlich ascites carcinoma.
Burns ER
Am J Anat; 1987 Jul; 179(3):308-13. PubMed ID: 3630958
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
